IN VIVO CHARACTERIZATION OF LESS PAINFUL PROPOFOL NANOEMULSION USING PALM OIL FOR INTRAVENOUS DRUG DELIVERY

  • BAYU EKO PRASETYO Department of Pharmaceutical Technology, Faculty of Pharmacy, Universitas Sumatera Utara, Medan, 20155, Indonesia
  • NORAZRINA AZMI Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia
  • AHMAD FUAD SHAMSUDDIN Faculty of Pharmacy and Health Sciences University Kuala Lumpur Royal College of Medicine Perak (UniKL RCMP) No. 3 Jalan Greentown 30450 Ipoh, Perak

Abstract

Objective: The objective of present work was to evaluate the effectiveness of propofol in nanoemulsion based palm oil that called as NEMS™, which was a choice of anesthetic drug to induce and maintenance general anesthesia to reduce pain on injection activity and also to evaluate the in vivo characterization of propofol in NEMS™.


Methods: Preparation of propofol nanoemulsion using NEMS™ technology has been performed for propofol 1% in NEMS™ (P1%), and propofol 2% in NEMS™ (P2%). Determination of free propofol concentration in aqueous phase was conducted using HPLC and rat paw lick test was evaluated as in vivo test to assay the intensity of pain on injection site. The sleep recovery test was conducted to evaluate the pharmacological effect and erythrocyte hemolysis test also conducted to ensure the safety of propofol in NEMS™. All of the test results were compared with Diprivan®1% as a positive standard.


Results: The contents of free propofol in formulation P1% and Diprivan®1% in aqueous-phase were 6.20±0.03 µg/ml and 15.02±0.33 µg/ml, respectively (*P<0.05). The rat paw lick test showed that the formulation P1% was significantly (*P<0.05) less painful when compared to Diprivan®1%. There were no significant differences in pharmacological effect for all of the formulations (*P>0.05). The erythrocyte haemolysis test show that all formulation still safe for our blood.


Conclusion: Palm oil can be used as a carrier for propofol and it was successfully reduced the free propofol contents and the intensity of pain on injection site in rats.

Keywords: Palm oil, NEMS™, Propofol, MCT/lCT, Nanoemulsion

References

1. Egan TD. Exploring the frontiers of propofol formulation strategy: is there life beyond the Milky Way? Br J Anaesth 2010;104:533-5.
2. Baker MT, Mohamed N. Propofol, the challenges of formulation. Anesthesiology 2005;103:860-76.
3. Prakash KD. Pain on injection of lipid-free propofol and propofol nanoemulsion containing medium-chain triglyceride: a comparative study. Anesth Analg 2005;101:1060-2.
4. Lee SK. Pain in injection with propofol. Korean J Anesthesiol 2010;59:297-8.
5. Saadawy I, Erturgrul E, Abdulaziz B. Painless injection of propofol: pretreatment with. M E J Anesth 2007;19:631-44.
6. Shimizu T, S Inomata, S Kihara, H Toyooka, J Brimacombe. Rapid injection reduces pain on injection with propofol. Eur J Anaesth 2005;22:394-6.
7. Banjong K, Siriwan D, Sujarit K, Malin T. Comparison on pain on injection of a small particle size-lipid nanoemulsion of propofol and standard propofol with or without lidocaine. J Med Assoc Thai 2005;88:1401-5.
8. Cheong MA, Kyo SK, Won JC. Ephedrine reduces the pain from propofol injection. Anesth Analg 2002;95:1293-6.
9. Hüseyin S, Omer Y, Ali S, Mehmet M, Sezai O, Güner D. Effect of saline dilution on propofol injection pain: comparison with lidocaine. Turkiye Klinikleri J Med Sci 2009;29:150-4.
10. Khouadja H, Arnous H, Tarmiz K, Beletaifa D, Brahim A, Brahem B, et al. Pain on injection of propofol: efficacy of paracetamol and lidocaine. Open J Anesth 2014;4:81-7.
11. Ba?ak N, Yakup Aksoy, Ayhan Kaydu, Omer Fatih Sahin. Lornoxicam use to reduce the pain associated with propofol injection. Libyan J Med 2017;12:1313093.
12. Nicholas CH, Sun, Andrew YC, Wong, Michael GI. A comparison of pain on intravenous injection between two preparations of propofol. Anesth Analg 2005;101:675-8.
13. Hiroshi O, Shinju O, Hiroshi I. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol. Can J Anesth 2005;52:595-9.
14. Yamakage M, Sohshi I, Jun-Ichi S, Akiyoshi N. Changes in concentrations of free propofol by modification of the solution. Anesth Analg 2005;101:385-8.
15. Sundarathiti P, Nuanjai B, Therawat C, Porpimon J, Wanadee R. A comparison of propofol LCT with propofol-LCT/MCT on pain of injection. J Med Assoc Thai 2007;90:2683-8.
16. Mukherjee S, Analava M. Health effects of palm oil. J Hum Ecol 2009;26:197-203.
17. Khosla P. Palm oil: a nutritional overview. AgroFOOD industry hi-tech Anno; 2006. p. 17.
18. Sundram K. Palm oil: chemistry and nutrition updates. Malaysian Palm Oil Board (MPOB), Kuala Lumpur; 2003.
19. Prasetyo BE, Norazrina A, Shamsuddin AF. Preparation and physical stability evaluation of palm oil-based nanoemulsion as a drug delivery system for propofol. JSKM 2018:16:5-1.
20. Schicher M, Margit P, Albin H, Ruth P, Andreas Z. In vitro release of propofol and binding capacity with regard to plasma constituents. Eur J Pharm Biopharm 2008;70:882-8.
21. Lu Y, Wang YJ, Tang Q. Formulation and thermal sterile stability of a less painful intravenous clarithromycin nanoemulsion containing vitamin E. Int J Pharm 2008;346:47-56.
22. Ravenelle F, Sandra G, Dorothee L. Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics. Pharm Res 2008;25:312-9.
23. Wang JJ, KC Sung, Oliver Y, Chih HY, Jia YF. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs. J Controlled Release 2006;115:140-9.
24. Date AA, Nagarsenker MS. Design and evaluation of microemulsions for improved parenteral delivery of propofol. AAPS PharmSciTech 2008;9:138-45.
25. Almajidi Y, Mahdi Z, Maraie N. Preparation and in vitro evaluation of montelukast sodium oral nanoemulsion. Int J Appl Pharm 2018;10:49-53.
26. Franklyne JS, Abinaya N, Andrew E, Nisha T, Amitava. Preparation and characterization of edible oil nanoemulsions for enhanced stability and oral delivery of curcumin. Int J Appl Pharm 2018;10:139-46.
27. Suminar MM, Mahdi J. Physical stability and antioxidant activity assay of nanoemulsion gel formulation containing tocotrienol. Int J Appl Pharm 2017;9 Suppl 1:140-3.
28. Ambesh SP, Prakash KD, Prabhat KS. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. Anesth Analg 1999;89:197-9.
29. Scott RPF, Saunders DA, Norman J. Propofol: clinical strategies for preventing the pain of injection. Anaesthesia 1988;43:492-4.
30. Ohmizo H, Obara S, Iwama H. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol. Can J Anaesth 2005;52:595-9.
31. Babl J, Doenicke A, Monch V. New formulation of propofol in an LCT/MCT nanoemulsion. Approach to reduce pain on injection. Eur Hosp Pharm 1995;1:15-21.
32. Lovell MW, Johnson HW, Hui HW, Gupta PK, Hsu CC. Less painful nanoemulsion formulations for intravenous administration of clarithromycin. Int J Pharm 1994;109:45-57.
33. Celozzi E, Lotti VJ, Stapley EO, Miller AK. An animal model for assessing pain-on-injection of antibiotics. J Pharmacol Meth 1980;4:285-9.
34. Chellman G, George FF, Lance OL, Tim EM. Rat paw-lick/muscle irritation model for evaluating parenteral formulations for pain-on-injection and muscle damage. Toxicol Sci 1990;15:697-709.
35. Jumaa M, Muller BW. In vitro investigation of the effect of various isotonic substances in parenteral emulsions on human erythrocytes. Eur J Pharm Sci 1999;9:207-12.
36. Krzyzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. Int J Pharm 1997;152:193-200.
37. Ishii F, Nagasaka Y. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections. Coll Surf B: Biointerfaces 2004;37:43-7.
Statistics
36 Views | 26 Downloads
How to Cite
PRASETYO, B. E., AZMI, N., & SHAMSUDDIN, A. F. (2019). IN VIVO CHARACTERIZATION OF LESS PAINFUL PROPOFOL NANOEMULSION USING PALM OIL FOR INTRAVENOUS DRUG DELIVERY. International Journal of Applied Pharmaceutics, 11(4), 98-102. https://doi.org/10.22159/ijap.2019v11i4.33039
Section
Original Article(s)